Article

Glaucoma 2005 convenes in San Francisco this September

The agenda is set for Glaucoma 2005 on Saturday, Sept. 17 at the Ritz-Carlton, San Francisco, with a program aimed at helping ophthalmologists master the tools and techniques of glaucoma diagnosis and therapy.

Major topics will include the benefits and limitations of new diagnostic technologies and how to integrate them into clinical practice, an evidence-based clinical approach to risk assessment in the ocular hypertensive and glaucoma patient, innovations in surgery for the patient with glaucoma, and challenging clinical cases.

Upon completion of this course, participants will have learned specific benefits and limitations of diagnostic technologies, practical approaches to risk assessment and management of the patient with suspected glaucoma, advances in surgical techniques, and practical approaches to challenging glaucoma cases. Participants will be able to incorporate their knowledge of these advances in glaucoma diagnosis and therapy into their clinical practices, thus providing the best possible care to their patients, either directly or through appropriate informed referrals.

The University of Medicine and Dentistry of New Jersey Center for Continuing and Outreach Education designates this educational activity for a maximum of 6 hours of category 1 credit toward the AMA Physician’s Recognition Award. The program is supported through an unrestricted educational grant from Pfizer Ophthalmics. To register or request more information, call 888/248-0036 or 218/723-9130 or visit http://otcme.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.